Where next for prophylaxis against pre‐eclampsia?

F. Broughton Pipkin, Professor of Reproductive Physiology, University of Nottingham ; C. Crowther, Senior LecturerlConsultant, Queen Victoria Hospital, Adelaide, Australia ; M. de Swiet, Consultant Physician, Queen Charlotte's Hospital and University College London; L. Duley, National Perinatal Epidemiology Unit ; A. Judd, Deputy Chief Hospital Pharmacist, Leeds General Injirmary ; R. J. Lilford, Professor of Health Services Research, Department of Public Health Medicine, University of Birmingham; J. Onwude, Consultant Obstetrician and Gynaecologist, Chelmsford, Essex; C. Prentice, Professor of Medicine, University of Leeds and Lee& General In$rmary ; C. W. G. Redman, Professor of Obstetric Medicine, University of Oxford, John Radclifle Hospital; J. Roberts, Professor of Obstetrics and Gynaecology, University of Pittsburgh, Director, MageeWomen's Research Institute, and Chairman of the Perinatal Trials Group-National Institute of Health ; J. Thornton, Reader /Consultant, University of Leeds and Leeds General Infirmary; J. Walker, Professor of Obstetrics and Gynaecology, University of Leeds and St James's University Hospital